JP2002531069A - タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用 - Google Patents

タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用

Info

Publication number
JP2002531069A
JP2002531069A JP2000582560A JP2000582560A JP2002531069A JP 2002531069 A JP2002531069 A JP 2002531069A JP 2000582560 A JP2000582560 A JP 2000582560A JP 2000582560 A JP2000582560 A JP 2000582560A JP 2002531069 A JP2002531069 A JP 2002531069A
Authority
JP
Japan
Prior art keywords
hvr
rvr
nucleic acid
polypeptide
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000582560A
Other languages
English (en)
Japanese (ja)
Inventor
カーテイス，ロリ・エイ・ジエイ
Original Assignee
ミレニアム・フアーマシユーチカルズ・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミレニアム・フアーマシユーチカルズ・インコーポレーテツド filed Critical ミレニアム・フアーマシユーチカルズ・インコーポレーテツド
Publication of JP2002531069A publication Critical patent/JP2002531069A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
JP2000582560A 1998-11-13 1999-11-12 タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用 Pending JP2002531069A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US10832298P 1998-11-13 1998-11-13
US60/108,322 1998-11-13
US11407898P 1998-12-28 1998-12-28
US60/114,078 1998-12-28
US25863399A 1999-02-26 1999-02-26
US09/258,633 1999-02-26
US42113499A 1999-10-19 1999-10-19
US09/421,134 1999-10-19
PCT/US1999/026701 WO2000029577A1 (en) 1998-11-13 1999-11-12 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof

Publications (1)

Publication Number Publication Date
JP2002531069A true JP2002531069A (ja) 2002-09-24

Family

ID=27493638

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000582560A Pending JP2002531069A (ja) 1998-11-13 1999-11-12 タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用

Country Status (5)

Country Link
EP (1) EP1131433A1 (de)
JP (1) JP2002531069A (de)
AU (1) AU2148000A (de)
CA (1) CA2348479A1 (de)
WO (1) WO2000029577A1 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011037753A (ja) * 2009-08-11 2011-02-24 Japan Health Science Foundation Ｔｒｐｖ２の部分ペプチド
JP2013520961A (ja) * 2010-02-26 2013-06-10 ヴェンタナ メディカル システムズ， インク． 中期染色体の細胞遺伝学的解析

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999009140A1 (en) 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
DE69910538T2 (de) * 1998-01-22 2004-06-24 The Regents Of The University Of California, Oakland Nukleinsäuresequenzen, welche für capsaicin-rezeptoren kodieren
GB9827016D0 (en) 1998-12-08 1999-02-03 Merck Sharp & Dohme Receptor protein
GB9907097D0 (en) 1999-03-26 1999-05-19 Novartis Ag Organic compounds
US6482611B1 (en) 1999-09-23 2002-11-19 Neurogen Corporation Human capsaicin receptor and uses thereof
ZA200300255B (en) 2000-07-20 2004-09-28 Bristol Myers Squibb Pharma Co Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors.
DE10043674A1 (de) * 2000-09-02 2002-03-21 Gruenenthal Gmbh Antisense Oligonukleotide
WO2002018407A2 (de) * 2000-09-02 2002-03-07 Grünenthal GmbH Antisense oligonukleotide gegen vanilloid rezeptor 1
AU2001297015A1 (en) 2000-10-15 2002-04-29 Ortho-Mcneil Pharmaceutical, Inc. Improved ligand binding assays for vanilloid receptors
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7041068B2 (en) 2001-06-12 2006-05-09 Pelikan Technologies, Inc. Sampling module device and method
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7175642B2 (en) 2002-04-19 2007-02-13 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
CA2515418A1 (en) * 2003-02-12 2004-08-26 Bayer Healthcare Ag Hydroxy-tetrahydro-naphthalenylurea derivatives
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
US8282576B2 (en) 2003-09-29 2012-10-09 Sanofi-Aventis Deutschland Gmbh Method and apparatus for an improved sample capture device
WO2005040119A1 (en) 2003-10-01 2005-05-06 Bayer Healthcare Ag Tetrahydro-naphthalene and urea derivatives
WO2005037095A1 (en) 2003-10-14 2005-04-28 Pelikan Technologies, Inc. Method and apparatus for a variable user interface
WO2005044802A2 (en) 2003-11-08 2005-05-19 Bayer Healthcare Ag Tetrahydro-quinolinylurea derivatives as vrl antagonists
WO2005065414A2 (en) 2003-12-31 2005-07-21 Pelikan Technologies, Inc. Method and apparatus for improving fluidic flow and sample capture
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
US9820684B2 (en) 2004-06-03 2017-11-21 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
BRPI0513286A (pt) 2004-07-15 2008-05-06 Japan Tobacco Inc compostos de benzamida condensada e inibidores de atividade de receptor vanilóide subtipo (vr1), suas composições farmacêuticas, pacote comercial, fármaco e respectivos usos
US7906508B2 (en) 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
EP2265324B1 (de) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integriertes System zur Messung von Analyten
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998039448A2 (en) * 1997-03-07 1998-09-11 Human Genome Sciences, Inc. 186 human secreted proteins
WO1999009140A1 (en) * 1997-08-20 1999-02-25 The Regents Of The University Of California Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
DE69910538T2 (de) * 1998-01-22 2004-06-24 The Regents Of The University Of California, Oakland Nukleinsäuresequenzen, welche für capsaicin-rezeptoren kodieren
WO1999037765A1 (en) * 1998-01-27 1999-07-29 Smithkline Beecham Plc Human vanilloid receptor homologues
EP0943683A1 (de) * 1998-03-10 1999-09-22 Smithkline Beecham Plc Menschliches Vanilloid Rezeptorhomolog Vanilrep1
EP0953638A1 (de) * 1998-03-11 1999-11-03 Synthelabo Dem menschlichen Vanilloid Rezeptor ähnlicher Kationenkanal

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011037753A (ja) * 2009-08-11 2011-02-24 Japan Health Science Foundation Ｔｒｐｖ２の部分ペプチド
JP2013520961A (ja) * 2010-02-26 2013-06-10 ヴェンタナ メディカル システムズ， インク． 中期染色体の細胞遺伝学的解析

Also Published As

Publication number Publication date
WO2000029577A9 (en) 2000-09-28
WO2000029577A1 (en) 2000-05-25
AU2148000A (en) 2000-06-05
CA2348479A1 (en) 2000-05-25
EP1131433A1 (de) 2001-09-12

Similar Documents

Publication Publication Date Title
JP2002531069A (ja) タンパク質のカプサイシン／バニロイド受容体ファミリーの新規メンバー及びそれらの使用
JP2001517443A (ja) Ｔｎｆ受容体スーパーファミリーの新規な分子及びそれらの使用
CA2299055A1 (en) Novel molecules of the tango-77 related protein family and uses thereof
US8133689B2 (en) Members of the capsaicin/vanilloid receptor family of proteins and uses thereof
JP2002501078A (ja) Ｓｐｏｉｌタンパク質及び核酸分子並びにそれらの使用
US6225085B1 (en) LRSG protein and nucleic acid molecules and uses therefor
US20020150988A1 (en) Novel molecules of the FTHMA-070-related protein family and the T85-related protein family and uses thereof
US6380382B1 (en) Gene encoding a protein having diagnostic, preventive, therapeutic, and other uses
JP2002516079A (ja) 新規分泌型および膜会合型タンパク質ならびにそのための用途
AU753279B2 (en) Novel molecules of the T129-related protein family and uses thereof
EP1092038A1 (de) OCT1p, PROTEIN MIT HOMOLOGIE ZU DER ORGANISCHEN UND ZUCKERTRANSPORTER PROTEINFAMILIE UND DESSEN VERWENDUNG
JP2002528046A (ja) 新規レセプタースーパーファミリー分子およびそれについての用途
US6756212B1 (en) Isolated proteins and nucleic acid molecules having homology to the NIP2 protein and uses thereof
JP2002525117A (ja) Ｓｌｇｐタンパク質及び核酸分子並びにそれらの使用
US6485921B1 (en) UBCLP and uses thereof
US20020164330A1 (en) Novel molecules of the tango-77 related protein family and uses thereof
CA2348758A1 (en) Lymphoma associated molecules and uses therefor
US20040209287A1 (en) OCT1p, a protein having homology to the organic and sugar transporter family of proteins, and uses thereof
CA2363605A1 (en) Androgen-induced suppressor of cell proliferation and uses thereof
US20020086982A1 (en) Novel EBI-3-ALT protein and nucleic acid molecules and uses therefor
CA2422846A1 (en) Lymphoma associated molecules and uses therefor
EP1586660A1 (de) Neue Moleküle der T85-verwandten Proteinfamilie und ihre Verwendung
US20020115185A1 (en) Neuronal cell death associated molecules and uses therefor
AU4829199A (en) Novel molecules of the t110-related protein family and uses thereof

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060630

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20060630

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20060630

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20060630

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061031

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090721

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20091215